DE2851928C2 - - Google Patents

Info

Publication number
DE2851928C2
DE2851928C2 DE19782851928 DE2851928A DE2851928C2 DE 2851928 C2 DE2851928 C2 DE 2851928C2 DE 19782851928 DE19782851928 DE 19782851928 DE 2851928 A DE2851928 A DE 2851928A DE 2851928 C2 DE2851928 C2 DE 2851928C2
Authority
DE
Germany
Prior art keywords
cells
virus
rotavirus
medium
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19782851928
Other languages
German (de)
English (en)
Other versions
DE2851928A1 (de
Inventor
June Dalziel Blackheath London Gb Almeida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2851928A1 publication Critical patent/DE2851928A1/de
Application granted granted Critical
Publication of DE2851928C2 publication Critical patent/DE2851928C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12361—Methods of inactivation or attenuation
    • C12N2720/12364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE19782851928 1977-12-01 1978-11-30 Verfahren zur vermehrung von rotavirus in vitro Granted DE2851928A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5009477 1977-12-01
GB5390677 1977-12-24

Publications (2)

Publication Number Publication Date
DE2851928A1 DE2851928A1 (de) 1979-06-21
DE2851928C2 true DE2851928C2 (en:Method) 1987-06-04

Family

ID=26266615

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782851928 Granted DE2851928A1 (de) 1977-12-01 1978-11-30 Verfahren zur vermehrung von rotavirus in vitro

Country Status (10)

Country Link
US (1) US4205131A (en:Method)
JP (1) JPS5495789A (en:Method)
CH (1) CH646194A5 (en:Method)
DE (1) DE2851928A1 (en:Method)
DK (1) DK152516C (en:Method)
FI (1) FI63060C (en:Method)
FR (1) FR2410675A1 (en:Method)
GB (1) GB2009786B (en:Method)
NL (1) NL191183C (en:Method)
SE (1) SE445466B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33164E (en) * 1979-05-15 1990-02-13 Mobay Corporation Influenza vaccine production in liquid cell culture
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
US4624850A (en) * 1984-02-09 1986-11-25 Royal Children's Hospital Research Foundation Live attenuated human rotavirus vaccine
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5147639A (en) * 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
DK1213030T3 (da) * 1994-11-10 2009-07-20 Baxter Healthcare Sa Fremgangsmåde til fremstilling af biologiske produkter i protein-fri kultur
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
WO1998017785A1 (en) * 1996-10-18 1998-04-30 The Research Foundation For Microbial Diseases Of Osaka University Rotavirus antigens, vaccines and diagnostic drugs for infection with rotavirus, and processes for producing the same
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6656719B1 (en) * 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
FR2801900B1 (fr) * 1999-12-03 2004-02-27 Pasteur Merieux Serums Vacc Methode de production de cellules animales adherentes
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
DK1984007T3 (en) * 2006-02-13 2015-12-07 Oncolytics Biotech Inc Application of Low-dose local immunosuppression for amplification of viral oncolytic therapy
WO2007132480A2 (en) * 2006-05-12 2007-11-22 Bharat Biotech International Limited A composition useful as a vaccine
CN117070475B (zh) * 2023-10-13 2023-12-29 金宇保灵生物药品有限公司 牛轮状病毒无血清悬浮培养方法及其产品和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1539221A (en) * 1976-09-30 1979-01-31 Wellcome Found Viral preparations

Also Published As

Publication number Publication date
NL7811763A (nl) 1979-06-06
FI63060B (fi) 1982-12-31
US4205131A (en) 1980-05-27
FI783663A7 (fi) 1979-06-02
JPS5495789A (en) 1979-07-28
FR2410675A1 (fr) 1979-06-29
DK152516C (da) 1988-08-01
NL191183C (nl) 1995-03-01
DE2851928A1 (de) 1979-06-21
DK542878A (da) 1979-06-02
FR2410675B1 (en:Method) 1983-12-16
SE7812283L (sv) 1979-06-02
NL191183B (nl) 1994-10-03
FI63060C (fi) 1983-04-11
DK152516B (da) 1988-03-07
CH646194A5 (de) 1984-11-15
GB2009786A (en) 1979-06-20
JPS6150599B2 (en:Method) 1986-11-05
SE445466B (sv) 1986-06-23
GB2009786B (en) 1982-08-11

Similar Documents

Publication Publication Date Title
DE2851928C2 (en:Method)
DE69327307T2 (de) Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheit
DE69732407T2 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
DE2516274C2 (de) Verfahren zum Herstellen eines abgeschwächten Zytomegalie-Virus-Impfstoffes
DE2314076C3 (de) Verfahren zur Herstellung von karzinoembyonischem Antigen
Van der Veen et al. Establishment of two human cell strains from kidney and reticulosarcoma of lung
JPH08188515A (ja) 組織培養物において効能のあるトキソプラズマ ゴンデイ ブラデイゾイトワクチンの生産
CH504532A (de) Verfahren zur Züchtung pathogener Viren, Zellstamm zur Ausführung des Verfahrens und Anwendung des Verfahrens
Macdonald et al. Observations on viral tenosynovitis (viral arthritis) in Scotland
CH658192A5 (de) Tollwut-impfstoff und verfahren zu seiner herstellung.
CH429024A (de) Verfahren zur Herstellung eines lebendes, abgeschwächtes Masernvirus enthaltenden Impfstoffes
DE69615656T2 (de) Aviären infektiösen anämie mastgeflügel impfstoff
DE3854575T2 (de) Reassortantes Rotavirusvakzin.
DE69130206T2 (de) Impfstoff aus reassortiertem rotavirus
DE2058645C2 (de) Verfahren zur Herstellung eines stark abgeschwächten Newcastle-Disease-Virus-Lebendimpfstoffs
DE3878982T2 (de) Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
DE68927380T2 (de) Impfstoff
Mancini et al. Cultivation of avian encephalomyelitis virus in vitro. 1. In chick embryo neuroglial cell culture
US3629396A (en) Avian encephalomyelitis vaccine
CH455148A (de) Verfahren zur Vermehrung des Tollwutvirus
EP0158285B1 (de) Verfahren zur Gewinnung von Zellkulturen
DE2057544B2 (de) Impfstoff gegen ein neonatales Kälberdiarrhoevirus, Verfahren zu seiner Herstellung und seine Verwendung
US3733401A (en) Highly attenuated newcastle disease virus vaccine and production thereof
AT243435B (de) Verfahren zur Herstellung einer Tollwutvakzine
DE2121237C3 (de) Verwendung einer Zellinie zur Züchtung von Viren

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MALLINCKRODT VETERINARY, INC. (N.D.GES.D.STAATES D

8328 Change in the person/name/address of the agent

Free format text: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM. DR.JUR. DR.RER.NAT. MARX, L., DIPL.-PHYS. DR.RER.NAT., PAT.-ANWAELTE, 81677 MUENCHEN